Discover 1,621 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,621
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
for
Clear Cell Renal Cell Carcinoma
Location: Durham NC, Charlotte NC, Atlanta GA, Columbus OH,
Sponsor: Xencor, Inc.
Sex: All
Age: 18+
Code: NCT05433142
Phase1, Recruiting
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
for
Oral Mucositis
Location: Durham NC, Philadelphia PA, New York NY, Gainesville FL,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT00901732
Phase1, Phase2, Recruiting
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Location: Durham NC, Wynnewood PA, Columbus OH, New Haven CT,
Sponsor: Medtronic - MITG
Sex: All
Age: 18+
Code: NCT07351071
Recruiting
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
for
Advanced Solid Tumor Cancer
Location: Durham NC, Baltimore MD, Pittsburgh PA, Philadelphia PA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18+
Code: NCT04777994
Phase1, Recruiting
Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer
for
Breast Cancer
Location: Durham NC
Sponsor: National Center for Research Resources (NCRR)
Sex: Female
Age: 18 - 70+
Code: NCT00006433
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
Location: Wake Forest NC, Erie PA, The Woodlands TX, Bellaire TX,
Sponsor: Eyconis INC.
Sex: All
Age: 50+
Code: NCT07587515
Phase1, Phase2, Recruiting
Active & Responsive
Oxygen Toxicity: Mechanisms in Humans
for
Oxygen Toxicity, Hypercapnia, Seizures
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 45
Code: NCT05761756
Recruiting
Featured
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Chapel Hill NC, Philadelphia PA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT06332534
Phase3, Recruiting
Featured
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Chapel Hill NC, Roanoke VA, Fairfax VA, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase2, Phase3, Recruiting
Featured
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia (CLL)
Location: Chapel Hill NC, Winston-Salem NC, Charlotte NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04895436
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Durham NC, Fairfax VA, New York NY, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase2, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Durham NC, Huntersville NC, Fairfax VA, Louisville KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Effect of Mobilization in Conjunction With Exercise in Participants With a History of Chronic Ankle Instability
for
Ankle Sprains
Location: Fayetteville NC, Winchester VA
Sponsor: Shenandoah University
Sex: All
Age: 18 - 35
Code: NCT03428620
Recruiting
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
for
Heterozygous Familial Hypercholesterolemia,
Location: High Point NC, Philadelphia PA, Jacksonville FL,
Sponsor: Verve Therapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT06164730
Phase1, Recruiting
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
for
Musculoskeletal Injuries
Location: Fort Liberty NC, Bethesda MD
Sponsor: Womack Army Medical Center
Sex: All
Age: 18 - 44
Code: NCT05111925
Recruiting
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI